A new insight on the effects of Schiff Base Iron (III) complexes in breast cancer cells for clinical radiotherapy.

Purpose: Breast cancer is a significant global health concern, and researchers strive to enhance radiotherapy outcomes while minimizing the side effects. Schiff Base Iron (III) Complexes are one of the prospective elements that can be used as radiosensitizer or radioprotective agents in cancer radiotherapy. This study investigates the potential effects of Schiff base (ligand 2; L) with Fe(III) in MCF-7 breast cancer cells under clinical radiotherapy treatment.

The antimony(III)-bridged heteropolyanion sandwich dimers [Sb(II3(A-α-XW9O34)2]11- (X = SiIV, GeIV and C-shaped double-sandwich [SbIII6O2(PW6O26)(A-α-PW9O34)2]15-.

Interaction of potassium antimony(iii) tartrate hydrate K(2)(SbC(4)H(2)O(6))(2)·3H(2)O with the trilacunary Keggin derivatives [A-α-XW(9)O(34)](10-) (X = Si(IV), Ge(IV)) and [A-α-PW(9)O(34)](9-) in aqueous acidic medium (pH 4.8) resulted in three novel polyanions, [Sb(3)(A-α-XW(9)O(34))(2)](11-) (X = Si(IV) (1), Ge(IV) (2)) and [Sb(6)O(2)(A-PW(6)O(26))(A-α-PW(9)O(34))(2)](15-) (3), which were isolated as the hydrated potassium salts K(11)[Sb(3)(A-α-XW(9)O(34))(2)]·31H(2)O (X = Si(IV) (K-1), Ge(IV) (K-2)) and the mixed potassium-sodium salt K(14)Na[Sb(6)O(2)(A-PW(6)O(26))(A-α-PW(9)O(34))(2)]·61H(2)O (KNa-3) salts, respectively, and characterized by single-crystal X-ray diffraction, IR spectroscopy, as well as elemental and thermogravimetric analyses. The Sb(III)-containing polyanions 1-3 possess unique structural features, as they represent the first examples of sandwich-type POMs with trigonal-pyramidal Sb(III)O(3) linkers.

Alpha and beta isomers of tetrahafnium(IV) containing decatungstosilicates, [Hf4(OH)6(CH3COO)2(x-SiW10O37)2]12- (x = α, β).

The two dimeric, Hf-containing tungstosilicates [Hf(4)(OH)(6)(CH(3)COO)(2)(α-SiW(10)O(37))(2)](12-) (1) and [Hf(4)(OH)(6)(CH(3)COO)(2)(β-SiW(10)O(37))(2)](12-) (2) have been synthesized by reacting HfCl(4) with [γ-SiW(10)O(36)](8-) in potassium acetate solutions at pH = 3.6 and 4.8, respectively.